According to the latest data from the Hong Kong Stock Exchange, on January 28, JPMorgan increased its stake in Innovent Bio (01801) by 198,871 shares, with a transaction price of HK$83.829 per share, amounting to a total of approximately HK$16.67 million. Following this acquisition, its latest shareholding quantity stands at approximately 86.7841 million shares, representing a 5% stake in the company.